ARCT-2303
ARCT-2303-01
Phase 3 mab completed
Quick answer
ARCT-2303 for COVID-19 is a Phase 3 program (mab) at Arcturus Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcturus Therapeutics Holdings
- Indication
- COVID-19
- Phase
- Phase 3
- Modality
- mab
- Status
- completed